Anavex Life Sciences Corporation (AVXL)

Anavex Life Sciences Corporation (AVXL) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	12.55% 1.756	2.008	1.9582	1.8279	1.4652
Operating Expenses	10.86% 12.52	11.29	12.65	13.53	14.19
Benefits Costs and Expenses	15.67% 12.20	10.54	12.17	13.07	14.52
Costs And Expenses	15.67% 12.20	10.54	12.17	13.07	14.52
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	10.86% -12.52	-11.29	-12.65	-13.53	-14.19
Net Interest Income/Expense	12.55% 1.756	2.008	1.9582	1.8279	1.4652
Nonoperating Income/Loss	24.60% 2.078	2.756	2.4422	2.2917	1.1319
Income/Loss From Continuing Operations Before Tax	22.30% -10.44	-8.537	-10.21	-11.24	-13.06
Income Tax Expense/Benefit, Current	23.53% 0.105	0.085	-0.064	0.041	0.05
Income Tax Expense/Benefit	23.53% 0.105	0.085	-0.057	0.041	0.05
Income/Loss From Continuing Operations After Tax	22.32% -10.55	-8.622	-10.15	-11.28	-13.11
Net Income/Loss	22.32% -10.55	-8.622	-10.15	-11.28	-13.11
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.47% 82.46	82.08	-	-	-
Diluted Average Shares	0.47% 82.46	82.08	-	-	-
Basic Earnings Per Share	18.18% -0.13	-0.11	-	-	-
Diluted Earnings Per Share	18.18% -0.13	-0.11	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-